Kathryn Marie Frietze - Genetic Mutations

Author Information

Kathryn Marie Frietze is affiliated with the Department of Molecular Genetics and Microbiology at the School of Medicine, University of New Mexico Health Sciences, Albuquerque, NM, USA. Her research primarily focuses on the immunogenicity and protective capacity of vaccines, particularly those targeting infectious diseases such as Chlamydia trachomatis and dengue virus.

Research Contributions

Kathryn Marie Frietze has made significant contributions to the field of vaccine development and immunology. Her research includes the development and assessment of virus-like particle (VLP) vaccines and the use of deep sequence-coupled biopanning technology to analyze antibody responses. Notable studies include her work on a VLP vaccine against Chlamydia trachomatis and the development of bacteriophage VLP vaccines displaying conserved epitopes of dengue virus non-structural protein 1. Additionally, she has explored the use, hygiene, and risk perception of sexual enrichment aids among women, highlighting a gap in medical information provided to patients.

Aliases

Kathryn Marie Frietze is also known by the aliases Kathryn Frietze and Kathryn M Frietze.

Publication and Citation Metrics

Metric	Value
Total Citation Count	291
h-index	8
Total Number of Papers	24

Publications:

Immunogenicity and Protective Capacity of a Virus-like Particle Vaccine against Chlamydia trachomatis Type 3 Secretion System Tip Protein, CT584

DOI: 10.3390/vaccines10010111

Year: 2022

P157 Women commonly use sexual enrichment aids and rarely receive information from medical practitioners on hygiene and safety

DOI: 10.1136/SEXTRANS-2021-STI.262

Year: 2021

Development of Bacteriophage Virus-Like Particle Vaccines Displaying Conserved Epitopes of Dengue Virus Non-Structural Protein 1

DOI: 10.3390/vaccines9070726

Year: 2021

Sexual Enrichment Aids: A Mixed Methods Study Evaluating Use, Hygiene, and Risk Perception among Women.

DOI: 10.1080/00224499.2021.2015568

Year: 2021

Assessing Antibody Specificity in Human Serum Using Deep Sequence-Coupled Biopanning.

DOI: 10.1007/978-1-4939-9853-1_9

Year: 2020

Antibodies to Variable Domain 4 Linear Epitopes of the Chlamydia trachomatis Major Outer Membrane Protein Are Not Associated with Chlamydia Resolution or Reinfection in Women

DOI: 10.1128/mSphere.00654-20

Year: 2020

Expansion and Refinement of Deep Sequence-Coupled Biopanning Technology for Epitope-Specific Antibody Responses in Human Serum

DOI: 10.3390/v12101114

Year: 2020

Applying lessons from human papillomavirus vaccines to the development of vaccines against Chlamydia trachomatis

DOI: 10.1080/14760584.2018.1534587

Year: 2018

VLP-based vaccine induces immune control of Staphylococcus aureus virulence regulation

DOI: 10.1038/s41598-017-00753-0

Year: 2017

Pathogen-specific deep sequence-coupled biopanning: A method for surveying human antibody responses

DOI: 10.1371/journal.pone.0171511

Year: 2017

What Types of Genetic Mutations Can CGH Detect?

What is a Mutation?

How Do Environmental Mutations Affect Health?

How is PCR Used to Detect Genetic Mutations?

What are the Current Therapeutic Innovations?

Can Mutations be Repaired?

What are the Treatments for Autosomal Recessive Disorders?

Can Nucleotide Mutations Be Repaired?

What are Acridine Dyes?

How Do Genetic Mutations Influence Infectious Diseases?

Partnered Content Networks

Relevant Topics